Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database-Reference-Cited by-同舟云学术

Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database

Published:2017-11-09 Issue:4 Volume:38 Page:569-577
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Albrecht Katinka^ORCID,Huscher Dörte^ORCID,Buttgereit Frank,Aringer Martin,Hoese Guido,Ochs Wolfgang,Thiele Katja,Zink Angela^ORCID

Funder

Unconditional grants from the German Collaborative Arthritis Centers and from a consortium of 11 pharmaceutical companies to the German Academy.

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/article/10.1007/s00296-017-3874-3/fulltext.html

Reference23 articles.

1. Buttgereit F, Dejaco C, Matteson EL, Dasgupta B (2016) Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA 315:2442–2458

2. Matteson EL, Buttgereit F, Dejaco C, Dasgupta B (2016) Glucocorticoids for management of polymyalgia rheumatica and giant cell arteritis. Rheum Dis Clin North Am 42:75–90

3. Dejaco C, Singh YP, Perel P et al (2015) 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 74:1799–1807

4. Dasgupta B, Borg FA, Hassan N et al (2010) BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford) 49:1594–1597

5. Gabriel SE, Sunku J, Salvarani C, O’Fallon WM, Hunder GG (1997) Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum 40:1873–1878

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymyalgia rheumatica is a risk factor for more recalcitrant disease in giant cell arteritis: A retrospective cohort study;Seminars in Arthritis and Rheumatism;2024-10

2. Neue Ansätze in der immunologischen Therapie der Riesenzellarteriitis und Polymyalgia rheumatica;Arthritis und Rheuma;2024-04

3. Outcomes of polymyalgia rheumatica in real-world practice: a longitudinal cohort study;Romanian Journal of Internal Medicine;2024-03-12

4. Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis;Rheumatology International;2024-02-01

5. Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study;Biologics: Targets and Therapy;2023-12